Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Name: Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
Published: 2023
License: Public Domain

Galenicum Health · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

diabetes-mellitus type-2

bioequivalence, diabetes mellitus, type 2, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Related documents